HeartFlow

IPO

Decisive Coronary Care

Public · San Francisco, United States · Founded 2011 · $464.6M raised

Headquarters
San Francisco
Employees
501–1000
Founded
2011
Business Model
B2B
Total Funding
$464.6M
Last Round
$98.0M Convertible NoteMar 2025
Rounds
7
Type
Public

About

Heartflow is an AI-powered medical technology company empowering clinicians with precision tools to detect, understand, and manage coronary artery disease. Its platform includes FFR CT Analysis, Plaque Analysis, and Roadmap Analysis, enabling personalized cardiac care pathways. Heartflow has treated over 650,000 patients across more than 1,800 institutions with extensive peer-reviewed clinical evidence.

Summary

HeartFlow is a Healthcare company based in San Francisco, United States, founded in 2011. It has raised $464.6M in total across 7 rounds, most recently a $98.0M Convertible Note round in Mar 2025. Investors include Bain Capital Life Sciences, Andreessen Horowitz and GV.

Tech & App Stack

5 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

IPOAug 2025
$316.7M

Sign up to see all 8 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies